Please login to the form below

Not currently logged in
Email:
Password:

Piqray

This page shows the latest Piqray news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Novartis’ Piqray in combination with Faslodex for advanced breast cancer patients

NICE recommends Novartis’ Piqray in combination with Faslodex for advanced breast cancer patients

Novartis has announced that Piqray (alpelisib) has been recommended by the National Institute for Health and Care Excellence (NICE) for use in combination with Faslodex (fulvestrant) for the treatment of advanced ... The recommendation follows the

Latest news

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...